Skip to main content
. Author manuscript; available in PMC: 2014 May 14.
Published in final edited form as: Mol Carcinog. 2011 Oct 17;51(12):952–962. doi: 10.1002/mc.20866

Figure 2.

Figure 2

Effect of apigenin on cell cycle arrest and apoptosis in human prostate cancer cells. A, PC-3 and 22Rv1 cells treated with apigenin (20 μM and 40 μM) for 24h and distribution of cells in different stages of cell cycle was recorded and analyzed using FACS analysis. B, PC-3 and 22Rv1 cells were treated with apigenin (20 and 40μg/ml) for 24h and the number of cells undergoing apoptosis were determined using annexin-V staining. Data represents the mean ± SD of three different assays. *P <0.05, and **P <0.001 versus control. The details are provided in ‘materials and methods’.